CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-25 | Schlesinger Sarah J. Director | Grant or award | +12,647 | 88,211 | ||
| 2022-04-25 | Schlesinger Sarah J. Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2022-04-25 | Odysseas Kostas D Director | Grant or award | +12,647 | 92,207 | ||
| 2022-04-25 | Odysseas Kostas D Director | Grant or award · Non-statutory Stock Option | +10,000 | $10,000.00 | $100.0M | 0 |
| 2022-03-01 | Zhen Marianne Chief Accounting Officer | Grant or award | +6,691 | 38,872 | ||
| 2022-03-01 | Zhen Marianne Chief Accounting Officer | Grant or award · Non-statutory Stock Option | +15,000 | 20,000 | ||
| 2022-02-18 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −2,277 | $19.99 | $46K | 32,181 |
| 2021-11-19 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −758 | $17.05 | $13K | 34,458 |
| 2021-08-20 | Zhen Marianne Chief Accounting Officer | Sale | −1,129 | $15.89 | $18K | 35,364 |
| 2021-08-20 | Zhen Marianne Chief Accounting Officer | Sale | +1,129 | $15.89 | $18K | 35,364 |
| 2021-08-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −760 | $15.94 | $12K | 34,604 |
| 2021-08-19 | Zhen Marianne Chief Accounting Officer | Sale | −2,802 | $16.02 | $45K | 36,493 |
| 2021-05-24 | Bickerstaff George Director | Purchase | +10,000 | $13.46 | $135K | 124,560 |
| 2021-05-21 | Bickerstaff George Director | Purchase | +10,000 | $12.97 | $130K | 114,560 |
| 2021-05-21 | Raifeld Pavel Chief Executive Officer | Grant or award · Nonstatutory Stock Option | +100,000 | 350,000 | ||
| 2021-05-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −759 | $13.32 | $10K | 39,295 |
| 2021-05-20 | GLAXOSMITHKLINE PLC 10% owner | Sale | −32,005,260 | $12.25 | $392.1M | 0 |
| 2021-05-14 | Haimovitz Jules Director | Grant or award | +17,482 | 87,764 | ||
| 2015-08-07 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +245,828 | $3,485,841.04 | $856.9B | 32,005,260 |
| 2015-05-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +85,579 | $1,369,264.00 | $117.2B | 31,759,432 |
Page 8 of 10 · 181 trades